Ledger.Open graph →
SEC Form D · Amendment · filed August 8, 2018

SUTRO BIOPHARMA INC

Offering
$85.4M
Sold
$85.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Ryan L. Hanks · Charlotte, NCDirectorJennifer M. Appleton · Los Gatos, CADirectorMartin Beaulieu · La Jolla, CADirectorMatt Osborne · La Jolla, CAExec · DirectorWilliam M. Appleton · Los Gatos, CADirectorNeil F. Dyer · Charlotte, NCDirectorDavid A. Fredston · Santa Monica, CADirectorBruno H. Adoric · Santa Monica, CADirectorDaniel M. Hirschfeld · Solon, OHDirectorJoseph N. Marconi · Boston, MADirectorMichael M. Epstein · Boston, MAExec · DirectorDaniel W. Cummings · Boston, MADirectorVirgil B. Lawlis · South San Francisco, CADirectorMichael B. Dybbs · South San Francisco, CADirectorDaniel B. Petree · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗